{"id":13344,"date":"2024-02-08T11:46:33","date_gmt":"2024-02-08T10:46:33","guid":{"rendered":"https:\/\/www.humangenetik-umg.de\/?p=13344"},"modified":"2024-02-08T11:46:33","modified_gmt":"2024-02-08T10:46:33","slug":"activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome","status":"publish","type":"post","link":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/","title":{"rendered":"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][mk_padding_divider size=&#8221;30&#8243;][\/vc_column][\/vc_row][vc_row][vc_column][mk_image src=&#8221;https:\/\/www.humangenetik-umg.de\/wp-content\/uploads\/2024\/02\/news-visual-fgfr2-en.png&#8221; image_size=&#8221;full&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][mk_padding_divider size=&#8221;30&#8243;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=&#8221;.vc_custom_1707389073746{margin-bottom: 0px !important;}&#8221;]<strong>Expansion of the complex genotypic and phenotypic spectrum of <em>FGFR2<\/em>-associated neurocutaneous syndromes<\/strong><br \/>\nSchmidt J, Kaulfu\u00df S, Ott H, Gaubert M, Reintjes N, Bremmer F, Dreha-Kulaczewski S, Stroebel P, Yigit G, Wollnik B.<br \/>\n<em>Hum Genet<\/em> 2024 Jan 24. doi: 10.1007\/s00439-023-02634-1. Epub ahead of print.<\/p>\n[mk_button dimension=&#8221;flat&#8221; size=&#8221;medium&#8221; icon=&#8221;mk-icon-long-arrow-right&#8221; icon_anim=&#8221;side&#8221; url=&#8221;https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38265560&#8243; target=&#8221;_blank&#8221; bg_color=&#8221;#006699&#8243; btn_hover_bg=&#8221;#000000&#8243; btn_hover_txt_color=&#8221;#ffffff&#8221;]Article in PubMed[\/mk_button][mk_padding_divider size=&#8221;30&#8243;]\n[\/vc_column_text][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][mk_padding_divider size=&#8221;30&#8243;][\/vc_column][\/vc_row][vc_row][vc_column][mk_image src=&#8221;https:\/\/www.humangenetik-umg.de\/wp-content\/uploads\/2024\/02\/news-visual-fgfr2-en.png&#8221; image_size=&#8221;full&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][mk_padding_divider size=&#8221;30&#8243;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=&#8221;.vc_custom_1707389073746{margin-bottom: 0px !important;}&#8221;]Expansion of the complex genotypic and phenotypic spectrum of FGFR2-associated neurocutaneous syndromes Schmidt J, Kaulfu\u00df S, Ott H, Gaubert M, Reintjes N, Bremmer F, Dreha-Kulaczewski S, Stroebel P, Yigit G, Wollnik B. Hum Genet 2024 Jan 24. doi: 10.1007\/s00439-023-02634-1. Epub ahead of print. [mk_button dimension=&#8221;flat&#8221; size=&#8221;medium&#8221; icon=&#8221;mk-icon-long-arrow-right&#8221; icon_anim=&#8221;side&#8221; [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[51,52],"tags":[],"class_list":["post-13344","post","type-post","status-publish","format-standard","hentry","category-news","category-research"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome - Institut f\u00fcr Humangenetik<\/title>\n<meta name=\"description\" content=\"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome - Institut f\u00fcr Humangenetik\" \/>\n<meta property=\"og:description\" content=\"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"Institut f\u00fcr Humangenetik\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-08T10:46:33+00:00\" \/>\n<meta name=\"author\" content=\"KB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"KB\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/\"},\"author\":{\"name\":\"KB\",\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/#\/schema\/person\/521bbb2a6ceb55060a1ef5eccb794675\"},\"headline\":\"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome\",\"datePublished\":\"2024-02-08T10:46:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/\"},\"wordCount\":161,\"articleSection\":[\"News\",\"Research\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/\",\"url\":\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/\",\"name\":\"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome - Institut f\u00fcr Humangenetik\",\"isPartOf\":{\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/#website\"},\"datePublished\":\"2024-02-08T10:46:33+00:00\",\"author\":{\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/#\/schema\/person\/521bbb2a6ceb55060a1ef5eccb794675\"},\"description\":\"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome\",\"breadcrumb\":{\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.humangenetik-umg.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/#website\",\"url\":\"https:\/\/www.humangenetik-umg.de\/en\/\",\"name\":\"Institut f\u00fcr Humangenetik\",\"description\":\"Institut f\u00fcr Humangenetik der Universit\u00e4tsmedizin G\u00f6ttingen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.humangenetik-umg.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/#\/schema\/person\/521bbb2a6ceb55060a1ef5eccb794675\",\"name\":\"KB\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.humangenetik-umg.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/599107e4ecdfb329c5aa3823e054ce14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/599107e4ecdfb329c5aa3823e054ce14?s=96&d=mm&r=g\",\"caption\":\"KB\"},\"url\":\"https:\/\/www.humangenetik-umg.de\/en\/author\/boss\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome - Institut f\u00fcr Humangenetik","description":"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/","og_locale":"en_US","og_type":"article","og_title":"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome - Institut f\u00fcr Humangenetik","og_description":"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome","og_url":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/","og_site_name":"Institut f\u00fcr Humangenetik","article_published_time":"2024-02-08T10:46:33+00:00","author":"KB","twitter_card":"summary_large_image","twitter_misc":{"Written by":"KB","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/#article","isPartOf":{"@id":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/"},"author":{"name":"KB","@id":"https:\/\/www.humangenetik-umg.de\/en\/#\/schema\/person\/521bbb2a6ceb55060a1ef5eccb794675"},"headline":"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome","datePublished":"2024-02-08T10:46:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/"},"wordCount":161,"articleSection":["News","Research"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/","url":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/","name":"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome - Institut f\u00fcr Humangenetik","isPartOf":{"@id":"https:\/\/www.humangenetik-umg.de\/en\/#website"},"datePublished":"2024-02-08T10:46:33+00:00","author":{"@id":"https:\/\/www.humangenetik-umg.de\/en\/#\/schema\/person\/521bbb2a6ceb55060a1ef5eccb794675"},"description":"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome","breadcrumb":{"@id":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.humangenetik-umg.de\/en\/activating-fgfr2-variant-identified-as-causing-mosaic-neurocutaneous-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.humangenetik-umg.de\/en\/"},{"@type":"ListItem","position":2,"name":"Activating FGFR2 variant identified as causing mosaic neurocutaneous syndrome"}]},{"@type":"WebSite","@id":"https:\/\/www.humangenetik-umg.de\/en\/#website","url":"https:\/\/www.humangenetik-umg.de\/en\/","name":"Institut f\u00fcr Humangenetik","description":"Institut f\u00fcr Humangenetik der Universit\u00e4tsmedizin G\u00f6ttingen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.humangenetik-umg.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.humangenetik-umg.de\/en\/#\/schema\/person\/521bbb2a6ceb55060a1ef5eccb794675","name":"KB","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.humangenetik-umg.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/599107e4ecdfb329c5aa3823e054ce14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/599107e4ecdfb329c5aa3823e054ce14?s=96&d=mm&r=g","caption":"KB"},"url":"https:\/\/www.humangenetik-umg.de\/en\/author\/boss\/"}]}},"_links":{"self":[{"href":"https:\/\/www.humangenetik-umg.de\/en\/wp-json\/wp\/v2\/posts\/13344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.humangenetik-umg.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.humangenetik-umg.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.humangenetik-umg.de\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.humangenetik-umg.de\/en\/wp-json\/wp\/v2\/comments?post=13344"}],"version-history":[{"count":0,"href":"https:\/\/www.humangenetik-umg.de\/en\/wp-json\/wp\/v2\/posts\/13344\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.humangenetik-umg.de\/en\/wp-json\/wp\/v2\/media?parent=13344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.humangenetik-umg.de\/en\/wp-json\/wp\/v2\/categories?post=13344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.humangenetik-umg.de\/en\/wp-json\/wp\/v2\/tags?post=13344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}